Aberrant Thyroid-Stimulating Hormone Receptor Signaling Increases VEGF-A and CXCL8 Secretion of Thyroid Cancer Cells, Contributing to Angiogenesis and Tumor Growth.
Young Shin SongMin Joo KimHyun Jin SunHwan Hee KimHyo Shik ShinYoung A KimByung-Chul OhSun Wook ChoYoung Joo ParkPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2018)
Aberrant TSH receptor signaling modulates tumor angiogenesis by stimulating VEGF-A and CXCL8 secretion from PDTC cells and enhances tumor growth; thus, TSH suppression is beneficial for treating PDTCs.